Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Xerostomia 1Stomatitis 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Xylitol × Clear all
NCT04608773 2024-02-01

Blinded Dry Mouth Spray Crossover Study

University of Pittsburgh

Phase NA Completed
129 enrolled 12 charts
Head & Neck

Head and Neck Neoplasms, Xerostomia

NCT01898091 2017-03-06

OM

Medical University of South Carolina

Phase 2 Completed
50 enrolled 9 charts
Other

Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡